Objective:

To discuss widefield SS-OCTA technology, including its clinical applications, limitations, and future directions, emphasizing its significance in advancing retinal imaging.

Key Findings:

• Widefield OCTA provides 3D, depth-resolved imaging without the need for dye, making it safer than traditional methods. For instance, it is particularly beneficial for patients with allergies to fluorescein.
• It accurately detects peripheral nonperfused areas (NPAs) in diabetic retinopathy, aiding in disease severity assessment, as shown in recent studies.
• Widefield OCTA matches or outperforms traditional imaging in identifying retinal lesions, including intraretinal microvascular abnormalities.

Interpretation:

Widefield OCTA enhances the diagnostic capabilities for various retinal diseases by providing comprehensive imaging of peripheral vascular abnormalities.

Limitations:

• Image quality and resolution decrease with increased field of view, complicating detection of subtle changes, which is critical in early disease detection.
• Peripheral signal strength is often weaker, potentially mimicking NPAs, which can lead to misdiagnosis.
• More susceptible to motion artifacts compared to traditional OCTA, which can distort vascular structures and affect clinical interpretations.

Conclusion:

Despite its limitations, widefield OCTA represents a significant advancement in retinal imaging, with ongoing technological improvements expected to enhance its clinical utility and diagnostic accuracy.